Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients

Clinical Infectious Diseases

Volumn 43, Issue 9, 2006, Pages 1209-1212

  Núñez, Marina ^a,b   Soriano, Vincent ^a   López, Mariola ^a   Ballesteros, Celia ^a   Cascajero, Almudena ^a   González Lahoz, Juan ^a   Benito, Jose Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PADGEM PROTEIN; PROPIDIUM IODIDE; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMORBIDITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERINFECTION; T LYMPHOCYTE; APOPTOSIS; DRUG EFFECT; IMMUNOLOGY; PATHOLOGY;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS C; HIV INFECTIONS; HUMANS;

EID: 33750135814     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508355     Document Type: Article

References (23)

1. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and HCV coinfections. Lancet 2000; 356:1800-5.
2. De Luca A, Bugarini R, Cozzi A, et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naïve HIV-infected subjects. Arch Intern Med 2002; 162:2125-32.
3. Lincoln D, Petoumenos K, Dore G, Australian HIV Observational Database. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med 2003; 4:241-9.
4. Klein M, Lalonde R, Suissa S. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 33:365-72.
5. Braitstein P, Zala C, Yip B, et al. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program. J Infect Dis 2006; 193:259-68.
6. Soriano V, Martin JC, Gonzalez-Lahoz J. HIV-1 progression in hepatitis C infected drug users. Lancet 2001; 357:1361-2.
7. Gougeon M, Montagnier L. Apoptosis in AIDS. Science 1993; 260:1269-70.
8. Taya N, Torimoto Y, Shindo M, Hirai K, Hasebe C, Kohgo Y. Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br J Haematol 2000; 110:89-97.
9. Sulkowski M, Moore R, Mehta S, Chaisson R, Thomas D. Hepatitis C and progression pf HIV disease. JAMA 2002; 288:199-206.
10. Rockstroh J, Mocroft A, Soriano V, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192:992-1002.
11. Dronda F, Zamora J, Moreno S. CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use. AIDS 2004; 18:2210-2.
12. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with HIV type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442-8.
13. Iken K, Huang L, Bekele H, Schmidt EV, Koziel MJ. Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. Virology 2006; 346:363-72.
14. Toubi E, Kessel A, Peri R, et al. Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment. J Virol 2004; 78:11379-84.
15. Balasubramanian A, Munshi N, Koziel M, et al. Structural proteins of hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells. J Gen Virol 2005; 86:3291-301.
16. Siavoshian S, Abraham J, Thumann C, Kieny M, Schuster C. Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J Med Virol 2005; 75:402-11.
17. Benito J, López M, Martín J, et al. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or non-nucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses 2002; 18:1379-88.
18. Gougeon M. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 2003; 3:392-404.
19. Chang K, Thimme R, Melpolder J, et al. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33:267-76.
20. Dutoit V, Ciuffreda D, Comte D, Gonvers J, Pantaleo G. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur J Immunol 2005; 35:3493-504.
21. Toubi E, Kessel A, Goldstein L, et al. Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity. J Hepatol 2001; 35:774-80.
22. Hahn C, Cho Y, Kang B, Lester I, Hahn Y. The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 2000; 276:127-37.
23. Benito JM, Zabay JM, Gil J, et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 lymphocytes in the asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:128-35.